SCOMAZZON, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 798
AS - Asia 101
EU - Europa 101
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.002
Nazione #
US - Stati Uniti d'America 795
CN - Cina 73
IT - Italia 39
SE - Svezia 24
SG - Singapore 21
FI - Finlandia 12
DE - Germania 10
GB - Regno Unito 9
IN - India 5
CA - Canada 3
FR - Francia 3
BG - Bulgaria 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
NL - Olanda 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.002
Città #
Fairfield 157
Ashburn 86
Cambridge 75
Ann Arbor 61
Chandler 60
Houston 60
Woodbridge 60
Seattle 57
Wilmington 47
Padova 20
Singapore 16
Beijing 15
San Diego 13
Helsinki 10
New York 10
Boardman 8
Medford 8
Princeton 8
Guangzhou 7
Nanjing 7
Des Moines 6
Hebei 4
Jinan 4
London 4
Santa Clara 4
Tianjin 4
Los Angeles 3
North York 3
Pune 3
Shenyang 3
Taiyuan 3
Dallas 2
Marostica 2
Nanchang 2
Redwood City 2
Shanghai 2
Taizhou 2
Verona 2
Changsha 1
Copenhagen 1
Ferentino 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hefei 1
Holon 1
Jiaxing 1
Johannesburg 1
Kilburn 1
Ningbo 1
Nuremberg 1
Nutley 1
Phoenix 1
Redmond 1
Shenzhen 1
Sofia 1
Tokyo 1
Yinchuan 1
Totale 860
Nome #
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 169
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 149
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 133
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 130
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 124
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 120
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 114
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 96
Totale 1.035
Categoria #
all - tutte 3.556
article - articoli 3.556
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 12 24 17 20 37 35 43 35 23
2020/2021230 13 30 12 26 5 4 13 11 31 40 34 11
2021/2022146 15 24 16 5 12 10 10 9 6 3 13 23
2022/2023117 22 11 1 20 17 10 0 8 11 1 15 1
2023/202473 5 5 8 3 8 18 4 2 0 9 2 9
2024/202546 0 19 16 11 0 0 0 0 0 0 0 0
Totale 1.035